NU 17Z01 (Lexent Bio) - Blood Biomarker Analysis in Patients with Solid Tumors or Lymphoma

Project: Research project

Project Details

StatusFinished
Effective start/end date12/14/17 → 12/14/22

Funding

  • Lexent Bio, Inc. (NU 17Z01)